En Ren
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Photoacoustic and Ultrasonic Imaging
Papers in
-
- Nanoplatforms for cancer theranostics 23
-
- RNA Interference and Gene Delivery 11
- Extracellular vesicles in disease 5
- Advanced biosensing and bioanalysis techniques 5
- Co-authors
- Gang Liu (41 shared papers)Xin Pang (15 shared papers)Yang Zhang (17 shared papers)Chengchao Chu (20 shared papers)Peng Lv (6 shared papers)Yi Cheng (3 shared papers)Jing Zhu (4 shared papers)Junqing Wang (7 shared papers)
- Journals
- Advanced Functional Materials (3 papers)Small Methods (3 papers)Advanced Materials (2 papers)Advanced Science (2 papers)ACS Applied Materials & Interfaces (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
En Ren
45 papers receiving 2.3k citations
En Ren's Hit Papers
Peers
Comparison fields: 5 of 109
- Biomaterials 470
- Biomedical Engineering 1.4k
- Immunology 289
- Microbiology 74
- Materials Chemistry 561
Countries citing papers authored by En Ren
This map shows the geographic impact of En Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by En Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites En Ren more than expected).
Fields of papers citing papers by En Ren
This network shows the impact of papers produced by En Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by En Ren. The network helps show where En Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside En Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy Hit paper breakdown → | 2022 | 286 |
| 2 | 2019 | 224 | |
| 3 | 2019 | 201 | |
| 4 | 2019 | 147 | |
| 5 | 2019 | 143 | |
| 6 | 2020 | 136 | |
| 7 | 2018 | 126 | |
| 8 | 2019 | 85 | |
| 9 | 2020 | 84 | |
| 10 | 2020 | 63 | |
| 11 | 2020 | 60 | |
| 12 | 2021 | 54 | |
| 13 | 2022 | 50 | |
| 14 | 2020 | 50 | |
| 15 | 2022 | 44 | |
| 16 | 2020 | 42 | |
| 17 | 2018 | 42 | |
| 18 | 2021 | 40 | |
| 19 | 2021 | 38 | |
| 20 | 2024 | 34 |
About En Ren
En Ren is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Radiology, Nuclear Medicine and Imaging and Materials Chemistry, having authored 47 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (23 papers), RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (7 papers), Extracellular vesicles in disease (5 papers), Advanced Nanomaterials in Catalysis (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Biomaterials (470 citations), Biomedical Engineering (1.4k citations), Immunology (289 citations), Microbiology (74 citations) and Materials Chemistry (561 citations). En Ren has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Gang Liu, Xin Pang, Yang Zhang, Chengchao Chu, Peng Lv, Yi Cheng, Jing Zhu, Junqing Wang, Yunming Zhang and Chao Liu. Their work appears in journals such as Advanced Functional Materials, Small Methods, Advanced Materials, Advanced Science and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.